FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS

Letters | Coronavirus vaccine race: follow the science, not the politics

  • Regulators in the US, China and Russia are all rushing to approve vaccine candidates for use without adequate trials, raising questions about safety

Topic |   World Health Organization
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
FDA Commissioner Stephen Hahn looks on as US President Donald Trump announces that the agency is issuing an emergency authorisation for blood plasma as a coronavirus treatment, at the White House on August 23. The FDA move came after Trump accused it of slow-walking the therapy to harm his re-election chances. Photo: Getty Images / TNS
READ FULL ARTICLE